Need help finding what you are looking for?
Contact Us
PUBLISHER: The Business Research Company | PRODUCT CODE: 2070303
PUBLISHER: The Business Research Company | PRODUCT CODE: 2070303
Oncology Molecular Diagnostics Global Market Opportunities And Strategies To 2035
PUBLISHED:
PAGES: 396 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Oncology molecular diagnostics refers to a class of diagnostic tests and technologies that analyze genetic material, proteins, and other molecular biomarkers to detect, characterize, and monitor cancer. These diagnostics are used by healthcare providers, including oncologists, pathologists, and laboratory professionals, to identify specific mutations, gene expressions, and molecular signatures associated with different types of cancer.
The oncology molecular diagnostics market consists of sales by entities (organizations, sole traders and partnerships) of oncology molecular diagnostics that are utilized across various stages of cancer care, including early detection, diagnosis, prognosis, treatment selection, and monitoring of disease progression or recurrence. Oncology molecular diagnostics are often used when a patient presents symptoms suggestive of cancer, during routine screenings, or when selecting targeted therapies based on tumor genetics.
The global oncology molecular diagnostics market was valued at $3,202.6 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 11.0%.
Expansion Of Healthcare Infrastructure
During the historic period, the oncology molecular diagnostics market was driven by the expansion of healthcare infrastructure. As governments and healthcare organizations increasingly invested in strengthening healthcare systems, expanding diagnostic facilities, and improving access to advanced medical technologies, the adoption of molecular diagnostic solutions, including next-generation sequencing (NGS), liquid biopsy, and biomarker-based testing, expanded to support early cancer detection, accurate diagnosis, and personalized treatment planning. For instance, in May 2022, according to Australian Government, an official national authority responsible for public policy and healthcare system development, reported a record investment of $132 billion in the healthcare system for 2022-23, increasing to $140 billion by 2025-26, with a total commitment of $537 billion over the next four years, highlighting the growing focus on strengthening healthcare infrastructure and expanding access to advanced medical services. Therefore, the oncology molecular diagnostics market was driven by the expansion of healthcare infrastructure during the historic period.
Internet Of Things (IoT), Smart Infrastructure And Connected Ecosystems
Major companies in the oncology molecular diagnostics market are increasingly prioritizing Internet of Things (IoT)-enabled diagnostic ecosystems, smart infrastructure integration, connected liquid biopsy platforms, and real-time data exchange frameworks. These initiatives leverage interconnected diagnostic devices, cloud-based data platforms, and continuously integrated real-world evidence systems. For example, in January 2026, Guardant Health, a US-based company specializing in precision oncology and liquid biopsy diagnostics, announced a multi-year strategic collaboration with Merck & Co., a US-based pharmaceutical company specializing in oncology therapeutics, to develop companion diagnostics and commercialize new cancer therapies using the Guardant Infinity Smart platform, this collaboration integrates Guardant's connected liquid and tissue biopsy testing ecosystem with Merck's global clinical development infrastructure, enabling the use of diagnostic assays as real-time clinical trial enrollment tools, facilitating continuous biomarker monitoring, and supporting global commercialization of companion diagnostics and targeted therapies.
The global oncology molecular diagnostics market is concentrated, with large players operating in the market. The top 10 competitors in the market made up 41.95% of the total market in 2024.
Oncology Molecular Diagnostics Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for oncology molecular diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The oncology molecular diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider oncology molecular diagnostics; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products and supply chain.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by product, by technology and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for oncology molecular diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Instruments; Reagents; Other Products
- 2) By Technology: Polymerase Chain Reaction (PCR); In-Situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips And Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
- 3) By End User: Hospitals; Diagnostic Centers; Academic And Research Institutes; Other End Users
- Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Illumina Inc.; Danaher Corp.; Abbott Laboratories
- Countries: China; Australia; India; Indonesia; Taiwan; Japan; South Korea; USA; Germany; Italy; Spain; UK; France; Russia
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; oncology molecular diagnostics indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: ME6MOMDO01_O26Q1
Table of Contents
1 Executive Summary
- 1.1 Dashboard
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Oncology Molecular Diagnostics Market Definition And Segmentations
- 6.4 Market Segmentation By Product (Instruments, Reagents And Other Products)
- 6.5 Market Segmentation By Technology (Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA) And Other Technologies)
- 6.6 Market Segmentation By End User (Hospitals, Diagnostic Centers, Academic And Research Institutes And Other End Users)
7 Oncology Molecular Diagnostics Market, Overview Of Key Products/Services
- 7.1 Global Oncology Molecular Diagnostics Market Attractiveness Scoring And Analysis
- 7.1.1 Overview Of Market Attractiveness Framework
- 7.1.2 Quantitative Scoring Methodology
- 7.1.3 Market Attractiveness Scoring And Interpretation
- 7.1.4 Factor-Wise Evaluation
- 7.1.5 Strategic Implications And Recommendations
8 Major Market Trends
- 8.1 Key Technologies and Future Trends
- 8.1.1 Digitalization, Cloud, Big Data And Cybersecurity
- 8.1.2 Internet Of Things (IoT), Smart Infrastructure And Connected Ecosystems
- 8.1.3 Artificial Intelligence And Autonomous Intelligence
- 8.1.4 Industry 4.0 And Intelligent Manufacturing
- 8.1.5 Biotechnology, Genomics And Precision Medicine
- 8.2 Major Trends
- 8.2.1 Expansion Of Companion Diagnostics And Integrated Genomic Profiling Ecosystems
- 8.2.2 Advancement Of Comprehensive Genomic Profiling And Integrated Assay Platforms
- 8.2.3 Rising Adoption Of RNA-Based Liquid Biopsy And Multiomic Profiling Platforms
- 8.2.4 Expansion Of Liquid Biopsy-Based Comprehensive Genomic Profiling
9 Global Oncology Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
- 9.1 Global Oncology Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 9.1.1 Political
- 9.1.2 Economic
- 9.1.3 Social
- 9.1.4 Technological
- 9.1.5 Environmental
- 9.1.6 Legal
- 9.2 Analysis Of End User (B2B)
- 9.2.1 Hospitals
- 9.2.2 Diagnostic Centers
- 9.2.3 Academic And Research Institutes
- 9.2.4 Other End Users
- 9.3 Global Oncology Molecular Diagnostics Market Size And Growth Analysis
- 9.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
- 9.4.1 Market Drivers 2020 - 2025
- 9.4.2 Market Restraints 2020 - 2025
- 9.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
- 9.6 Forecast Growth Contributors/Factors
- 9.6.1 Quantitative Growth Contributors
- 9.6.2 Drivers
- 9.6.3 Restraints
10 Global Oncology Molecular Diagnostics Total Addressable Market (TAM) Analysis
- 10.1 Definition And Scope of Total Addressable Market (TAM)
- 10.2 Methodology And Assumptions
- 10.2.1 Total Addressable Market for the Oncology Molecular Diagnostics Market - Business to Business (B2B)
- 10.2.2 TAM Comparison Analysis
11 Global Oncology Molecular Diagnostics Market Segmentation
- 11.1 Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.2 Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.3 Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.4 Global Oncology Molecular Diagnostics Market, Sub Segmentation Of Instruments, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.5 Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.6 Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12 Oncology Molecular Diagnostics Market, Regional and Country Analysis
- 12.1 Global Oncology Molecular Diagnostics Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.2 Global Oncology Molecular Diagnostics Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13 Asia-Pacific Market
- 13.1 Asia-Pacific Market Summary
- 13.1.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.2 Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.3 Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.4 Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5 China Market
- 13.5.1 China Market Summary
- 13.5.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.5.3 China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5.4 China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5.5 China Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.6 India Market
- 13.6.1 India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.6.2 India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.6.3 India Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.7 Japan Market
- 13.7.1 Japan Market Summary
- 13.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.7.3 Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.7.4 Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.7.5 Japan Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.8 Australia Market
- 13.8.1 Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.8.2 Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.8.3 Australia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.9 South Korea Market
- 13.9.1 South Korea Market Summary
- 13.9.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.9.3 South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.9.4 South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.9.5 South Korea Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.10 Taiwan Market
- 13.10.1 Taiwan Market Summary
- 13.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.10.3 Taiwan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.10.4 Taiwan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.10.5 Taiwan Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14 South East Asia Market
- 14.1 South East Asia Market Summary
- 14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 14.3 South East Asia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.4 South East Asia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.5 South East Asia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6 Indonesia Market
- 14.6.1 Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6.2 Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6.3 Indonesia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15 Western Europe Market
- 15.1 Western Europe Market Summary
- 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 15.3 Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.4 Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.5 Western Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6 UK Market
- 15.6.1 UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6.2 UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6.3 UK Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7 Germany Market
- 15.7.1 Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7.2 Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7.3 Germany Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8 France Market
- 15.8.1 France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8.2 France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8.3 France Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9 Italy Market
- 15.9.1 Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9.2 Italy Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9.3 Italy Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.10 Spain Market
- 15.10.1 Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.10.2 Spain Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.10.3 Spain Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16 Eastern Europe Market
- 16.1 Eastern Europe Market Summary
- 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.3 Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.4 Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5 Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6 Russia Market
- 16.6.1 Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6.2 Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6.3 Russia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17 North America Market
- 17.1 North America Market Summary
- 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 17.3 North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.4 North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.5 North America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.6 USA Market
- 17.6.1 USA Market Summary
- 17.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 17.6.3 USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.6.4 USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.6.5 USA Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.7 Canada Market
- 17.7.1 Canada Market Summary
- 17.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 17.7.3 Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.7.4 Canada Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.7.5 Canada Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
18 South America Market
- 18.1 South America Market Summary
- 18.2 South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.3 South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.4 South America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.5 Brazil Market
- 18.5.1 Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.5.2 Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.5.3 Brazil Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
19 Middle East Market
- 19.1 Middle East Market Summary
- 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 19.3 Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.4 Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.5 Middle East Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
20 Africa Market
- 20.1 Africa Market Summary
- 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 20.3 Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.4 Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.5 Africa Oncology Molecular Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
21 Competitive Landscape And Company Profiles
- 21.1 Oncology Molecular Diagnostics Market Competitive Landscape And & Market Share 2024
- 21.1.1 Top 10 Companies (Ranked by revenue/share)
- 21.2 Company Profiles
- 21.3 F. Hoffmann-La Roche AG (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 21.4 Thermo Fisher Scientific Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 21.5 Illumina Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 21.6 Danaher Corp. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 21.7 Abbott Laboratories (Company Overview, Products and Services, Business Strategy, Financial Overview)
22 Other Major And Innovative Companies
- 22.1 Siemens Healthcare AG (Company Overview, Products and Services)
- 22.2 QIAGEN N.V. (Company Overview, Products and Services)
- 22.3 Agilent Technologies (Company Overview, Products and Services)
- 22.4 Becton Dickinson and Company (Company Overview, Products and Services)
- 22.5 bioMerieux SA (Company Overview, Products and Services)
- 22.6 Bio-Rad Laboratories Inc. (Company Overview, Products and Services)
- 22.7 Sysmex Corporation (Company Overview, Products and Services)
- 22.8 Exact Sciences Corp. (Company Overview, Products and Services)
- 22.9 Guardant Health Inc. (Company Overview, Products and Services)
- 22.10 Biocartis Group NV (Company Overview, Products and Services)
- 22.11 Hologic Inc. (Company Overview, Products and Services)
- 22.12 Invitae Corporation (Company Overview, Products and Services)
- 22.13 NeoGenomics Laboratories, Inc. (Company Overview, Products and Services)
- 22.14 Myriad Genetics Inc. (Company Overview, Products and Services)
- 22.15 Tempus AI (Company Overview, Products and Services)
23 Competitive Benchmarking
24 Competitive Dashboard
25 Oncology Molecular Diagnostics Market - Company Scoring Matrix
- 25.1 Innovation & Brand Leaders
- 25.2 Emerging Innovators
- 25.3 Brand-Driven Traditionalists
- 25.4 Niche or Local Followers
26 Upcoming Startups In the Market
27 Key Mergers And Acquisitions
- 27.1 LabGenomics USA Acquired Integrated Molecular Diagnostics (IMD) CLIA labs
- 27.2 Eurobio Scientific Acquired EndoPredict from Myriad Genetics
- 27.3 Quest Diagnostics Incorporated Acquired Haystack Oncology
- 27.4 Freenome Holdings Inc. Acquired Oncimmune Ltd
28 Recent Developments
- 28.1 Expansion Of Proteomics-Based Precision Diagnostics And AI-Driven Treatment Response Prediction
- 28.2 Acceleration Of Rapid NGS-Based Companion Diagnostics And Decentralized Tumor Profiling
29 Opportunities And Strategies
- 29.1 Global Oncology Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
- 29.2 Global Oncology Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
- 29.3 Global Oncology Molecular Diagnostics Market In 2030 - Growth Strategies
- 29.3.1 Market Trend Based Strategies
- 29.3.2 Competitor Strategies
30 Oncology Molecular Diagnostics Market, Conclusions And Recommendations
- 30.1 Conclusions
- 30.2 Recommendations
- 30.2.1 Product
- 30.2.2 Place
- 30.2.3 Price
- 30.2.4 Promotion
- 30.2.5 People
31 Appendix
- 31.1 Geographies Covered
- 31.2 Market Data Sources
- 31.3 Research Methodology
- 31.4 Currencies
- 31.5 The Business Research Company
- 31.6 Copyright and Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.